> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Akorn Betamethasone Dipropionate Lotion Approved
- URL: https://www.fdaweb.com/akorn-betamethasone-dipropionate-lotion-approved/
- Published: 2019-10-15T12:00:00.000Z
- Updated: 2026-09-15T01:56:28.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5145258

FDA has approved an Akorn ANDA for betamethasone dipropionate lotion USP (augmented), 0.05%, a corticosteroid indicated for relieving inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age and older. Sales of the generic lotion are estimated at $10 million annually. The product will be manufactured at Akorn’s Amityville, NY manufacturing facility, the company says.